Compare KLXE & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KLXE | POM |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Other Specialty Stores |
| Sector | Energy | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.6M | 47.1M |
| IPO Year | 2018 | N/A |
| Metric | KLXE | POM |
|---|---|---|
| Price | $2.50 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 236.7K | ★ 796.0K |
| Earning Date | 05-07-2026 | 05-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $636,600,000.00 | N/A |
| Revenue This Year | $3.89 | N/A |
| Revenue Next Year | $4.95 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.46 | $0.19 |
| 52 Week High | $3.45 | $6.43 |
| Indicator | KLXE | POM |
|---|---|---|
| Relative Strength Index (RSI) | 50.26 | 66.04 |
| Support Level | $2.14 | $0.21 |
| Resistance Level | $3.10 | $0.43 |
| Average True Range (ATR) | 0.24 | 0.04 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 42.53 | 95.64 |
KLX Energy Services Holdings Inc is a growth-oriented provider of diversified oilfield services to onshore oil and natural gas exploration and production (E&P) companies operating in both conventional and unconventional plays in all of the active basins throughout the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Southwest region.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.